AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 49 filers reported holding AUTOLUS THERAPEUTICS PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $501,978 | -82.9% | 210,915 | -86.8% | 0.00% | -100.0% |
Q1 2023 | $2,943,717 | -14.5% | 1,599,846 | -11.7% | 0.00% | 0.0% |
Q4 2022 | $3,441,278 | +40.7% | 1,811,199 | +58.5% | 0.00% | 0.0% |
Q3 2022 | $2,445,000 | -60.2% | 1,142,605 | -47.4% | 0.00% | -50.0% |
Q2 2022 | $6,148,000 | -58.0% | 2,172,257 | -38.2% | 0.00% | -33.3% |
Q1 2022 | $14,647,000 | +60.7% | 3,512,513 | +100.0% | 0.00% | +50.0% |
Q4 2021 | $9,115,000 | -45.0% | 1,756,243 | -30.6% | 0.00% | -33.3% |
Q3 2021 | $16,586,000 | -9.6% | 2,532,134 | -8.3% | 0.00% | -25.0% |
Q2 2021 | $18,344,000 | +7575.3% | 2,762,754 | +6530.2% | 0.00% | – |
Q1 2021 | $239,000 | +40.6% | 41,669 | +119.2% | 0.00% | – |
Q4 2020 | $170,000 | +9.0% | 19,008 | +42.2% | 0.00% | – |
Q3 2020 | $156,000 | -98.3% | 13,368 | -97.7% | 0.00% | -100.0% |
Q2 2020 | $9,287,000 | +166.5% | 579,344 | -0.4% | 0.00% | +50.0% |
Q1 2020 | $3,485,000 | +2192.8% | 581,704 | +4940.3% | 0.00% | – |
Q4 2019 | $152,000 | -86.8% | 11,541 | -83.8% | 0.00% | -100.0% |
Q2 2019 | $1,148,000 | – | 71,285 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,530,657 | $23,126,000 | 1.85% |
TFG Asset Management GP Ltd | 2,500,000 | $16,375,000 | 1.00% |
Nantahala Capital Management | 2,936,791 | $19,236,000 | 0.61% |
MYDA Advisors LLC | 171,953 | $1,126,000 | 0.32% |
SABBY MANAGEMENT, LLC | 300,000 | $1,965,000 | 0.27% |
Regency Capital Management Inc.\DE | 57,000 | $373,000 | 0.26% |
Ikarian Capital, LLC | 544,819 | $3,568,000 | 0.25% |
Eversept Partners, LP | 398,074 | $2,607,385 | 0.18% |
Henry James International Management Inc. | 54,047 | $354,000 | 0.11% |
Alphabet Inc. | 698,262 | $4,574,000 | 0.11% |